Cargando…

Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma

Early relapse after hepatectomy for intrahepatic cholangiocarcinoma (ICC) has a tremendous influence on the long-term survival outcomes of ICC patients. The purpose of our study was to investigate risk factors for early tumor relapse and confirm whether early relapse was correlated with ICC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hua, Wang, Jie, Li, Zehuan, Yang, Yi, Yang, Liuxiao, Zhang, Yong, Shi, Yinghong, Cao, Ya, Zhou, Jian, Wang, Zheng, Chen, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737003/
https://www.ncbi.nlm.nih.gov/pubmed/31555597
http://dx.doi.org/10.3389/fonc.2019.00854
_version_ 1783450592742473728
author Yang, Hua
Wang, Jie
Li, Zehuan
Yang, Yi
Yang, Liuxiao
Zhang, Yong
Shi, Yinghong
Cao, Ya
Zhou, Jian
Wang, Zheng
Chen, Qing
author_facet Yang, Hua
Wang, Jie
Li, Zehuan
Yang, Yi
Yang, Liuxiao
Zhang, Yong
Shi, Yinghong
Cao, Ya
Zhou, Jian
Wang, Zheng
Chen, Qing
author_sort Yang, Hua
collection PubMed
description Early relapse after hepatectomy for intrahepatic cholangiocarcinoma (ICC) has a tremendous influence on the long-term survival outcomes of ICC patients. The purpose of our study was to investigate risk factors for early tumor relapse and confirm whether early relapse was correlated with ICC patients' long-term survival outcomes. Three hundred and twenty-two consecutive ICC patients undergoing partial hepatectomy at Liver Surgery Department of Zhongshan Hospital (Fudan University, Shanghai, China) between January 2005 and December 2011 were included in this retrospectively study. The definition of early relapse had been described as tumor relapse within 24 months after hepatectomy in ICC patients. We identified a total of 168 ICC patients with early relapse and 23 ICC patients with late relapse after hepatectomy. From the time of relapse, the long-term survival outcomes were worse among patients who had early vs. late relapse (median OS 16.5 vs. 44.7 months, respectively; P < 0.0001). The overall survival of the early relapse group was lower than that of the late relapse group (P < 0.0001). Multivariate Cox regression analysis indicated that multiple tumors (hazard ratio [HR], 1.951; 95% CI, 1.382–2.755; P < 0.001), lymphonodus metastasis (HR, 1.517; 95% CI, 1.061–2.168; P = 0.022), and higher serum CA19-9 levels (HR, 1.495; 95% CI, 1.095–2.039; P = 0.011) were independent risk factors of early relapse. Moreover, multiple tumors (HR, 1.641; 95% CI, 1.120–2.406; P = 0.011), lymphonodus metastasis (HR, 2.008; 95% CI, 1.367–2.949; P < 0.001), elevated NLR (HR, 1.921; 95% CI, 1.331–2.774; P < 0.001) and higher serum CA19-9 levels (HR, 1.990; 95% CI, 1.409–2.812; P < 0.001) were independent predictors of overall survival for ICC patients with early relapse. Collectively, our findings demonstrated that multiple tumors, lymphonodus metastasis, and higher serum CA19-9 levels were associated with the increased risks of early relapse and worse prognoses of ICC after curative-intent resection.
format Online
Article
Text
id pubmed-6737003
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67370032019-09-25 Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma Yang, Hua Wang, Jie Li, Zehuan Yang, Yi Yang, Liuxiao Zhang, Yong Shi, Yinghong Cao, Ya Zhou, Jian Wang, Zheng Chen, Qing Front Oncol Oncology Early relapse after hepatectomy for intrahepatic cholangiocarcinoma (ICC) has a tremendous influence on the long-term survival outcomes of ICC patients. The purpose of our study was to investigate risk factors for early tumor relapse and confirm whether early relapse was correlated with ICC patients' long-term survival outcomes. Three hundred and twenty-two consecutive ICC patients undergoing partial hepatectomy at Liver Surgery Department of Zhongshan Hospital (Fudan University, Shanghai, China) between January 2005 and December 2011 were included in this retrospectively study. The definition of early relapse had been described as tumor relapse within 24 months after hepatectomy in ICC patients. We identified a total of 168 ICC patients with early relapse and 23 ICC patients with late relapse after hepatectomy. From the time of relapse, the long-term survival outcomes were worse among patients who had early vs. late relapse (median OS 16.5 vs. 44.7 months, respectively; P < 0.0001). The overall survival of the early relapse group was lower than that of the late relapse group (P < 0.0001). Multivariate Cox regression analysis indicated that multiple tumors (hazard ratio [HR], 1.951; 95% CI, 1.382–2.755; P < 0.001), lymphonodus metastasis (HR, 1.517; 95% CI, 1.061–2.168; P = 0.022), and higher serum CA19-9 levels (HR, 1.495; 95% CI, 1.095–2.039; P = 0.011) were independent risk factors of early relapse. Moreover, multiple tumors (HR, 1.641; 95% CI, 1.120–2.406; P = 0.011), lymphonodus metastasis (HR, 2.008; 95% CI, 1.367–2.949; P < 0.001), elevated NLR (HR, 1.921; 95% CI, 1.331–2.774; P < 0.001) and higher serum CA19-9 levels (HR, 1.990; 95% CI, 1.409–2.812; P < 0.001) were independent predictors of overall survival for ICC patients with early relapse. Collectively, our findings demonstrated that multiple tumors, lymphonodus metastasis, and higher serum CA19-9 levels were associated with the increased risks of early relapse and worse prognoses of ICC after curative-intent resection. Frontiers Media S.A. 2019-09-04 /pmc/articles/PMC6737003/ /pubmed/31555597 http://dx.doi.org/10.3389/fonc.2019.00854 Text en Copyright © 2019 Yang, Wang, Li, Yang, Yang, Zhang, Shi, Cao, Zhou, Wang and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Hua
Wang, Jie
Li, Zehuan
Yang, Yi
Yang, Liuxiao
Zhang, Yong
Shi, Yinghong
Cao, Ya
Zhou, Jian
Wang, Zheng
Chen, Qing
Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title_full Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title_fullStr Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title_full_unstemmed Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title_short Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
title_sort risk factors and outcomes of early relapse after curative resection of intrahepatic cholangiocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737003/
https://www.ncbi.nlm.nih.gov/pubmed/31555597
http://dx.doi.org/10.3389/fonc.2019.00854
work_keys_str_mv AT yanghua riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT wangjie riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT lizehuan riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT yangyi riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT yangliuxiao riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT zhangyong riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT shiyinghong riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT caoya riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT zhoujian riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT wangzheng riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma
AT chenqing riskfactorsandoutcomesofearlyrelapseaftercurativeresectionofintrahepaticcholangiocarcinoma